BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 16, 2003
View Archived Issues
With Increasing Product Sales, Genzyme Beats Q3 Estimates
Genzyme Corp. beat consensus earnings estimates for the third quarter, without taking into account the company's purchase of SangStat Medical Corp., and raised its fourth-quarter and year-end financial outlook. (BioWorld Today)
Read More
U.S.-Approved Human Embryonic Stem Cells Recruited To Generate Transplantable Scarcity Of Organs
Read More
Immunex, Abgenix Revise Plans To Advance ABX-EGF For Cancer
Read More
Correction
Read More
Favrille Raises $10.6M To Push NHL Product To Phase III Trial
Read More
Sunesis In-Licenses Cancer Compound From Dainippon
Read More
Other News To Note
Read More
Biotech Comes On Strong: 'Second-Best' Year Ever?
Read More